AAAAAA

   
Results: 1-8 |
Results: 8
THE VENOUS THROMBOTIC RISK IN NONSURGICAL PATIENTS
Authors: BOUTHIER J
Citation: J. Bouthier, THE VENOUS THROMBOTIC RISK IN NONSURGICAL PATIENTS, Drugs, 52, 1996, pp. 16-28
THE VENOUS THROMBOTIC RISK IN NONSURGICAL PATIENTS - DISCUSSION
Authors: HAAS S BOUTHIER J",BOWLING
Citation: S. Haas et Bouthier J",bowling, THE VENOUS THROMBOTIC RISK IN NONSURGICAL PATIENTS - DISCUSSION, Drugs, 52, 1996, pp. 28-29
COMPARISON OF THE EFFICACY AND SAFETY OF LOW-MOLECULAR-WEIGHT HEPARINS AND UNFRACTIONATED HEPARIN IN THE INITIAL TREATMENT OF DEEP VENOUS THROMBOSIS - AN UPDATED METAANALYSIS - DISCUSSION
Authors: BOUTHIER J LEIZOROWICZ A SAMAMA MM
Citation: J. Bouthier et al., COMPARISON OF THE EFFICACY AND SAFETY OF LOW-MOLECULAR-WEIGHT HEPARINS AND UNFRACTIONATED HEPARIN IN THE INITIAL TREATMENT OF DEEP VENOUS THROMBOSIS - AN UPDATED METAANALYSIS - DISCUSSION, Drugs, 52, 1996, pp. 37-37
COMPARATIVE DISPOSITION OF ENOXAPARIN IN TOTAL HIP-REPLACEMENT (THR) PATIENTS AND IN HEALTHY-VOLUNTEERS GIVEN SUBCUTANEOUSLY A 30 MG ENOXAPARIN DOSE 2 TIMES DAY FOR 7 DAYS
Authors: COLLIGNON F SAHA A OZOUX ML FURMAN WK SPIRO I MCCORMACK A CAPLAIN H THEBAULT JJ FRYDMAN A BOUTHIER J
Citation: F. Collignon et al., COMPARATIVE DISPOSITION OF ENOXAPARIN IN TOTAL HIP-REPLACEMENT (THR) PATIENTS AND IN HEALTHY-VOLUNTEERS GIVEN SUBCUTANEOUSLY A 30 MG ENOXAPARIN DOSE 2 TIMES DAY FOR 7 DAYS, Thrombosis and haemostasis, 73(6), 1995, pp. 970-970
COMPARISON OF THE PHARMACOKINETIC PROFILES OF 3 LOW-MOLECULAR-MASS HEPARINS - DALTEPARIN, ENOXAPARIN AND NADROPARIN - ADMINISTERED SUBCUTANEOUSLY IN HEALTHY-VOLUNTEERS (DOSES FOR PREVENTION OF THROMBOEMBOLISM)
Authors: COLLIGNON F FRYDMAN A CAPLAIN H OZOUX ML LEROUX Y BOUTHIER J THEBAULT JJ
Citation: F. Collignon et al., COMPARISON OF THE PHARMACOKINETIC PROFILES OF 3 LOW-MOLECULAR-MASS HEPARINS - DALTEPARIN, ENOXAPARIN AND NADROPARIN - ADMINISTERED SUBCUTANEOUSLY IN HEALTHY-VOLUNTEERS (DOSES FOR PREVENTION OF THROMBOEMBOLISM), Thrombosis and haemostasis, 73(4), 1995, pp. 630-640
LACK OF INTERACTION ON THE HEMOSTASIS BALANCE BETWEEN NICORANDIL AND ACENOCOUMAROL IN ISCHEMIC-HEART-DISEASE PATIENTS
Authors: FRYDMAN A BOUVIER JL ROBINET A MOREL C TAIEB H YVENOU L KAPLAN P BOUTHIER J
Citation: A. Frydman et al., LACK OF INTERACTION ON THE HEMOSTASIS BALANCE BETWEEN NICORANDIL AND ACENOCOUMAROL IN ISCHEMIC-HEART-DISEASE PATIENTS, Thrombosis and haemostasis, 69(6), 1993, pp. 678-678
COMPARATIVE CLEARANCE PROFILE OF ENOXAPARIN AND UNFRACTIONATED HEPARIN IN MAN GIVEN BOTH MEDICATIONS BY THE SUBCUTANEOUS ROUTE
Authors: BARA L BENDETOWICZ AV CAPLAIN H COLLIGNON F LEROUX Y BOUTHIER J THEBAULT JJ FRYDMAN A SAMAMA MM
Citation: L. Bara et al., COMPARATIVE CLEARANCE PROFILE OF ENOXAPARIN AND UNFRACTIONATED HEPARIN IN MAN GIVEN BOTH MEDICATIONS BY THE SUBCUTANEOUS ROUTE, Thrombosis and haemostasis, 69(6), 1993, pp. 768-768
COMPARATIVE PHARMACOKINETICS OF ENOXAPARIN [LOVENOX-ASTERISK, CLEXANE-ASTERISK] (30-MG BID) AND UNFRACTIONATED HEPARIN (5,000-U TID) DURINGREPEATED SUBCUTANEOUS ADMINISTRATION IN MAN
Authors: COLLIGNON F OZOUX ML FRYDMAN A CAPLAIN H LEROUX Y KAPLAN P THEBAULT JJ BOUTHIER J
Citation: F. Collignon et al., COMPARATIVE PHARMACOKINETICS OF ENOXAPARIN [LOVENOX-ASTERISK, CLEXANE-ASTERISK] (30-MG BID) AND UNFRACTIONATED HEPARIN (5,000-U TID) DURINGREPEATED SUBCUTANEOUS ADMINISTRATION IN MAN, Thrombosis and haemostasis, 69(6), 1993, pp. 859-859
Risultati: 1-8 |